| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |